Global Infection Prevention Devices Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Infection Prevention Devices Market Analysis

The infection prevention devices market is essential for minimizing the risk of infections in healthcare settings, which can lead to complications and increased healthcare costs. This market includes a range of devices such as sterilization equipment, infection prevention supplies, medical waste disposal products, and disinfectants. Growing awareness regarding healthcare-associated infections (HAIs) and stringent regulations around infection control are key drivers of the market. Additionally, the increasing focus on hygiene, safety, and the adoption of advanced technologies, such as automated sterilization systems and antimicrobial coatings, are spurring market growth. Recent developments in the market include innovations in disposable infection control devices and more efficient sterilization systems, addressing the growing need for effective infection prevention in hospitals, clinics, and long-term care facilities. The rising prevalence of chronic diseases and surgeries also contributes to the demand for these devices, further driving the market’s expansion.

Infection Prevention Devices Market Size

The global infection prevention devices market size was valued at USD 2.16 billion in 2024 and is projected to reach USD 3.50 billion by 2032, with a CAGR of 6.20% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Infection Prevention Devices Market Trends

“Rise of Disposable Infection Prevention Products”

The infection prevention devices market is evolving with advancements in technology and increased focus on reducing healthcare-associated infections (HAIs). Innovations in sterilization devices, antimicrobial coatings, and automated infection control systems are leading the charge. One notable trend is the rise of disposable infection prevention products, such as single-use sterilization wraps and gloves, which ensure higher hygiene standards and reduce the risk of cross-contamination. Additionally, there is a growing demand for digital and automated solutions that streamline infection prevention protocols, improving operational efficiency in healthcare settings. The market is driven by stringent regulations and the rising prevalence of chronic diseases, necessitating more advanced infection control measures in hospitals and other healthcare facilities. These developments highlight a shift toward safer and more efficient infection prevention solutions.

Report Scope and Infection Prevention Devices Market Segmentation         

Infection Prevention Devices Market Definition

Infection prevention devices are medical tools and products designed to reduce the risk of infections in healthcare settings. These devices include sterilization equipment, disinfectants, medical waste disposal systems, and personal protective equipment (PPE). They are used to prevent the spread of pathogens, control healthcare-associated infections (HAIs), and maintain hygiene standards in hospitals, clinics, and other medical environments. These devices play a critical role in safeguarding both patients and healthcare workers by ensuring proper sanitation and infection control.

Infection Prevention Devices Market Dynamics

Drivers

• Rising Incidence of Healthcare-Associated Infections

The rising incidence of healthcare-associated infections (HAIs), particularly those resulting from surgical procedures, prolonged hospital stays, and the use of invasive medical devices, is significantly driving the demand for infection prevention devices. These infections pose serious risks to patient health, leading to longer recovery times, increased healthcare costs, and sometimes, severe complications. As a result, healthcare facilities are focusing more on adopting advanced infection control measures, including sterilization equipment, medical waste management products, and personal protective equipment (PPE). This growing concern over HAIs and the need to enhance patient safety is a key driver propelling the infection prevention devices market forward.

• Increasing Prevalence of Diabetes

The aging population and the increasing prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and respiratory conditions, are contributing to more frequent hospital visits, surgeries, and longer recovery periods. These factors lead to a higher risk of infections, particularly in patients with compromised immune systems. As a result, healthcare providers are under pressure to implement stringent infection prevention measures, driving the demand for advanced infection prevention devices. These devices, including sterilization equipment, advanced wound care products, and protective gear, are essential to minimize infection risks, ensuring better patient outcomes and enhancing safety in medical settings. This growing need is a significant driver for the infection prevention devices market.

Opportunities

• Growing Awareness in Emerging Markets

As healthcare infrastructure continues to improve in emerging economies, there is a growing emphasis on infection prevention to ensure safer healthcare environments. This shift is largely driven by an increase in healthcare investments, the expansion of hospitals and clinics, and greater awareness of healthcare-associated infections. With these advancements, the demand for infection prevention devices, such as sterilization equipment, air filtration systems, and personal protective equipment, is on the rise. These developments present a significant market opportunity for companies specializing in infection prevention technologies, particularly in emerging markets where healthcare modernization is rapidly accelerating, providing a lucrative growth avenue.

• Innovations in Antimicrobial Coatings

Innovations in antimicrobial coatings, advanced sterilization methods, and smart infection monitoring systems are significantly enhancing the effectiveness of infection prevention devices. Antimicrobial coatings, applied to surfaces and medical tools, help reduce the risk of infection by preventing microbial growth, making healthcare environments safer. Advanced sterilization methods, such as hydrogen peroxide vaporization and UV light sterilization, are improving infection control efficiency in hospitals and clinics. Meanwhile, smart infection monitoring systems use real-time data to track infection risks and ensure timely interventions. These technological advancements create a market opportunity for companies to develop and offer cutting-edge infection prevention solutions to meet growing healthcare demands.

Restraints/Challenges

• Competition and Price Pressure

The growing number of players in the infection prevention devices market, including low-cost manufacturers, is creating intense competition, which is driving down prices. As more companies enter the market, particularly those offering affordable alternatives, there is increased pressure on established players to reduce their prices while maintaining quality. This price competition can make it difficult for companies to sustain profitability, especially for those investing in advanced technologies and high-quality products that come with higher production costs. As a result, companies may face challenges in balancing product innovation with the need to remain competitive in a price-sensitive market.

•  High Costs of Advanced Devices

The high cost of advanced infection prevention devices, such as sterilization equipment, antimicrobial-coated surfaces, and automated disinfection systems, presents a significant market restraint, particularly in resource-constrained healthcare settings. These devices, while highly effective in preventing infections, often come with substantial upfront and maintenance costs that make them difficult to implement in underfunded hospitals and clinics. In low-income regions or developing economies, budget limitations may prevent healthcare facilities from adopting these advanced technologies, hindering market growth. As a result, the cost barrier remains a critical challenge for broader adoption, especially where the demand for effective infection control measures is high but financial resources are limited.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Infection Prevention Devices Market Scope

The market is segmented on the basis of product and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Infection Prevention Supplies
• Medical Waste Disposable Devices
• Infection Prevention Equipment

End-User

• Hospitals
• Lifescience Industries
• Clinical Laboratories
• Others

Infection Prevention Devices Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, product, and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the infection prevention devices market, driven by the growing number of surgical procedures, increased government-funded research and development activities, and the rising geriatric population. The region's advanced healthcare infrastructure further supports the adoption of infection control technologies. Additionally, the focus on improving patient safety and infection prevention in healthcare settings contributes to the market's dominance in North America.

Asia Pacific is emerging as a significant growth region for the infection prevention devices market, fueled by the expanding healthcare infrastructure and rising healthcare awareness. The increasing number of surgeries, combined with growing concerns about healthcare-associated infections, is driving demand for advanced infection control technologies.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Infection Prevention Devices Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Infection Prevention Devices Market Leaders Operating in the Market Are:

• ASP (U.S.)
• Cardinal Health (U.S.)
• PAUL HARTMANN AG (Germany)
• Mölnlycke Health Care AB (Sweden)
• 3M (U.S.)
• B. Braun SE (Germany)
• Medline Industries, LP. (U.S.)
• ANSELL LTD (Australia)
• Medivators Inc. (U.S.)
• The Clorox Company (U.S.)
• Contec, Inc. (U.S.)
• Getinge (Sweden)
• GOJO Industries, Inc. (U.S.)
• Baxter (U.S.)
• Cygnus Medical (U.S.)
•  Micro-Scientific, LLC. (U.S.)
• STERIS (U.K.)
• Terumo Corporation (Japan)

Latest Developments in Infection Prevention Devices Market

• In November 2023, a research team from Washington State University developed an innovative 3D-printed surgical device that demonstrated the ability to eliminate 87% of germs responsible for staph infections in laboratory tests. This groundbreaking technology shows promise in significantly reducing the risk of infections during and after surgical procedures. The device represents a major advancement in infection prevention, combining 3D printing technology with antimicrobial properties to enhance patient safety in clinical settings
• In October 2023, Protection Paints introduced Vira-Protect, a durable and effective paint designed to support infection control. This innovative paint incorporates silver ions, which are blended with a water-based, polyurethane-compatible formula to provide long-lasting antimicrobial protection. Vira-Protect offers a novel solution for enhancing hygiene and preventing the spread of infections in healthcare and public spaces
• In September 2023, Sodexo and Ecolab joined forces to address hospital-acquired infections (HAIs) by utilizing Ecolab's Bioquell hydrogen peroxide vapor technology. This collaboration aims to enhance infection control in healthcare settings, significantly reducing the risk of disease transmission. By integrating advanced disinfection technology, the partnership seeks to improve patient safety and prevent the spread of infections within medical facilities
• In August 2023, Fortive's Advanced Sterilization Products unveiled the STERRAD VELOCITY in Asia, a state-of-the-art biological indicator and process challenge device designed for quick and dependable sterilization of medical instruments. This innovative technology ensures faster turnaround times while maintaining high standards of sterility. By enhancing the efficiency and reliability of sterilization processes, STERRAD VELOCITY aims to meet the growing demand for effective infection control in healthcare facilities across Asia
• In June 2023, Nanosonics launched Nanosonics AuditPro, a digital tool aimed at helping healthcare professionals assess and manage infection prevention practices. This innovative platform provides real-time data and insights, enabling healthcare facilities to monitor and optimize their infection control efforts. By streamlining infection prevention audits, Nanosonics AuditPro enhances operational efficiency and supports improved patient safety across healthcare settings

SKU-46397